UnitedHealth Group Inc (NYSE:UNH) Director Richard T. Burke sold 20,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total value of $5,268,200.00. Following the completion of the transaction, the director now directly owns 1,720,112 shares in the company, valued at $453,094,701.92. The transaction was disclosed in a legal filing with the SEC, which is available at this link.
Shares of UNH opened at $265.31 on Friday. The company has a market cap of $252.81 billion, a PE ratio of 26.35, a PEG ratio of 1.56 and a beta of 0.71. UnitedHealth Group Inc has a 1 year low of $186.00 and a 1 year high of $271.16. The company has a debt-to-equity ratio of 0.63, a quick ratio of 0.75 and a current ratio of 0.75.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $3.04 by $0.10. The business had revenue of $56.09 billion for the quarter, compared to analysts’ expectations of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. The company’s revenue for the quarter was up 12.1% on a year-over-year basis. During the same period in the prior year, the firm earned $2.46 EPS. equities analysts forecast that UnitedHealth Group Inc will post 12.72 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 18th. Stockholders of record on Friday, September 7th will be given a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a dividend yield of 1.36%. The ex-dividend date of this dividend is Thursday, September 6th. UnitedHealth Group’s dividend payout ratio is currently 35.75%.
UnitedHealth Group declared that its board has authorized a stock buyback plan on Wednesday, June 6th that authorizes the company to buyback 100,000,000 outstanding shares. This buyback authorization authorizes the healthcare conglomerate to reacquire shares of its stock through open market purchases. Shares buyback plans are often an indication that the company’s board believes its stock is undervalued.
A number of research analysts recently commented on the company. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, June 19th. Cantor Fitzgerald reissued a “buy” rating and issued a $300.00 price target on shares of UnitedHealth Group in a report on Thursday, July 5th. BMO Capital Markets boosted their price target on UnitedHealth Group from $285.00 to $300.00 and gave the stock a “positive” rating in a report on Thursday, June 21st. ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, September 11th. Finally, SunTrust Banks assumed coverage on UnitedHealth Group in a report on Monday, June 11th. They issued a “buy” rating and a $300.00 price target on the stock. Two investment analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $272.43.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Welch Group LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $106,000. Blue Chip Partners Inc. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $107,000. Bamco Inc. NY bought a new position in shares of UnitedHealth Group during the 1st quarter valued at approximately $117,000. Northwest Wealth Management LLC bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $117,000. Finally, Fort L.P. bought a new position in shares of UnitedHealth Group during the 2nd quarter valued at approximately $119,000. 85.39% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What are CEFs?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.